Market Notice 135/19 - Information regarding the rights issue from NextCell Pharma AB

The last day of trading in the company’s shares NXTCL including the right to receive subscription rights is May 28, 2019. The first day excluding the right to obtain the rights is May 29, 2019.

One (1) share entitles the owner to one (1) subscription right. Three (3) subscription rights entitle the owner to subscribe for two (2) new shares, at the price of SEK 3,25 per share (2:3 á SEK 3,25).  

Trading with subscription rights will take place from June 4, 2019 until June 18, 2019 on Spotlight Stock Market.

Trading with the paid subscribed shares will take place from June 4, 2019 until the registration of the issue at Bolagsverket.  

The subscription period lasts from   June 4, 2019 to June 20, 2019.

Information about the subscription right:  

Shortname: NXTCL TR
ISIN-code: SE0012702520
Orderbook-ID: 57DP
CFI: RSSXXR
FISN: NEXTCELLPH/SUBS RTS NL PD
First day of trading: June 4
Last day of trading: June 18
Market Segment: SPSE
MIC Code: XSAT
Tick table/liquidity band #:
A (Other instruments)

Information about the paid subscribed share:    

Shortname: NXTCL BTA
ISIN-code: SE0012702538
Orderbook-ID: 57DN
CFI: ESNUFR
FISN: NEXTCELLPH/SH
Trading period: June 4, 2019 until the registration of the issue at Bolagsverket.
Market Segment: SPSE
MIC Code: XSAT
Tick table/liquidity band #:
A (Other instruments)

Please be advised that if the rights issue give rise to a conversion factor, all overnight orders in the company’s orderbook will be deleted. If so this will occur after closing on May 28, 2019. 

Stockholm May 24, 2019

Spotlight Stock Market
08-511 68 000
info@spotlightstockmarket.com 

Om oss

NextCells affärsidé är att utveckla och kommersialisera stamcellsprodukter i första hand för behandling av autoimmun diabetes och som immunosuppression vid njurtransplantation. Utöver detta erbjuds i bifirman Cellaviva blivande föräldrar att ta tillvara på sitt nyfödda barns stamceller för barnets och familjens eventuella framtida medicinska behov.

Prenumerera

Dokument & länkar